Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072449
Status:
TERMINATED
Last Update Posted:
2013-08-28
First Post:
2003-11-04
Brief Title:
Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| primary central nervous system non-Hodgkin lymphoma | View |